New Treatments
Researching Faster Cures
TB Alliance is not just developing new drugs, but changing the way TB drugs are developed.
Learn MoreThe Latest From TB Alliance
Join us at the 53rd Union World Conference on Lung Health, taking place online on 8 - 11 November 2022
Statement from Mel Spigelman, MD, President and CEO, TB Alliance
TB by the Numbers
1.6 Million
Tuberculosis (TB) is a global pandemic, killing someone approximately every 20 seconds — about 1.6 million people every year.
Get the facts6-30 Months
Today's TB drug regimen takes too long to cure, is too complicated to administer, and can be toxic.
Learn More30+ Projects
Promise in the pipeline means new hope in stopping TB.
Reaching Those In Need
Delivering Treatments
TB Alliance's mission is not complete until new drugs are in the hands of those who need them.
Learn More
Transforming TB Treatment
Charting the Course
We've all come to know the impact of infectious diseases, but we also know the power of science.
Learn MoreMore news:
- PAN-TB Collaboration to Advance Investigational Tuberculosis Drug Regimens to Phase 2 Clinical Trials
- Shortfall in TB Research and Development Funding Persists as COVID-19 Erodes Hard-Won Gains
- With tuberculosis resurgent after two years of COVID-19-inspired neglect, TB Alliance is awarded USAID funding to develop new treatments
